Skip to main content
. 2021 Aug 2;9(8):e002547. doi: 10.1136/jitc-2021-002547

Table 3.

Overview of immunological responses against E6 and E7 peptide pools

Patient Ex vivo Clinical E6-1 E6-2 E7
Response Response IFNy TNFa IL2 CD107a IFNy TNFa IL2 CD107a IFNy TNFa IL2 CD107a
1 Yes CR CD4 D0 <0.1% 1.1 <0.1% 0.4 <0.1% 1.8 1.3 0.4 <0.1% 1.2 1.2 0.4
D56 <0.1% 0.4 0.4 0.7 3.4 0.5 0.3 0.9 2.0 0.6 1.4 0.7
CD8 D0 <0.1% n.d. n.d <0.1% <0.1% n.d. n.d. <0.1% 1.5 n.d. n.d. <0.1%
D56 <0.1% n.d. <0.1% <0.1% 8.7 n.d. <0.1% <0.1% 3.8 n.d. 2.0 0.0
2 Yes CR CD4 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 0.8 <0.1% <0.1% <0.1%
D56 0.7 <0.1% <0.1% 15.9 2.3 <0.1% <0.1% 39.9 4.9 <0.1% <0.1% <0.1%
CD8 D0 0.9 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 0.2
D56 0.8 <0.1% <0.1% 9.5 1.7 <0.1% <0.1% 5.9 3.4 <0.1% <0.1% 6.3
3 No NR CD4 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 1.1 <0.1% <0.1% <0.1% 1.0 <0.1%
D56 <0.1% <0.1% 1.0 <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% <0.1% 1.0 <0.1%
CD8 D0 1.2 <0.1% 0.6 0.8 0.9 <0.1% 1.0 1.2 0.7 <0.1% 1.0 0.8
D56 <0.1% <0.1% 1.0 1.7 <0.1% <0.1% 1.0 1.0 <0.1% <0.1% 1.0 0.9
4 Yes PR CD4 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
D56 10.1 <0.1% 1.6 1.8 6.4 <0.1% 0.9 1.2 <0.1% <0.1% 4.0 <0.1%
CD8 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 1.2 1.2 <0.1% <0.1% 1.1 0.9
D56 24.2 <0.1% 3.6 1.0 12.4 n.d. 2.8 1.1 <0.1% <0.1% 2.1 1.0
5 No NR CD4 D0 <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% 1.2 <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% <0.1% 0.7
CD8 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
6 No NR CD4 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
CD8 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
7 Yes, PR CD4 D0 <0.1% <0.1% 5.2 <0.1% <0.1% <0.1% 6.0 <0.1% <0.1% <0.1% 2.4 <0.1%
Vaccine enhanced, D56 22.1 <0.1% <0.1% <0.1% 27.3 <0.1% <0.1% <0.1% 19.8 <0.1% <0.1% <0.1%
not induced CD8 D0 13.8 <0.1% <0.1% 1.2 5.3 <0.1% <0.1% 0.8 <0.1% <0.1% <0.1% 0.8
D56 6.4 <0.1% <0.1% 0.7 7.0 <0.1% <0.1% 1.7 6.3 <0.1% <0.1% 0.8
8 Yes PR CD4 D0 <0.1% <0.1% <0.1% 1.4 <0.1% <0.1% <0.1% 1.7 <0.1% <0.1% <0.1% 1.4
D56 <0.1% <0.1% 2.3 1.5 3.2 <0.1% 1.9 1.8 <0.1% <0.1% 1.4 1.0
CD8 D0 <0.1% <0.1% <0.1% 0.8 1.7 <0.1% <0.1% 0.9 0.7 <0.1% <0.1% 1.1
D56 0.9 <0.1% 2.6 1.4 4.3 <0.1% 2.9 1.2 1.1 <0.1% <0.1% 1.0
9 No NR CD4 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% 1.0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
CD8 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% <0.1% <0.1%
10 No NR CD4 D0 <0.1% <0.1% <0.1% 0.6 <0.1% 1.1 <0.1% 1.1 <0.1% <0.1% <0.1% 0.7
D56 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 1.2 <0.1% <0.1% <0.1% <0.1%
CD8 D0 <0.1% <0.1% <0.1% 0.7 <0.1% <0.1% <0.1% 1.2 <0.1% <0.1% <0.1% 0.8
D56 <0.1% <0.1% <0.1% 1.2 <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% <0.1% 1.1
11 No NR CD4 D0 <0.1% <0.1% 1.7 <0.1% <0.1% <0.1% 0.7 <0.1% <0.1% <0.1% 1.0 1.8
D56 <0.1% <0.1% <0.1% 1.0 <0.1% <0.1% 0.9 1.0 <0.1% <0.1% 0.6 0.9
CD8 D0 <0.1% <0.1% <0.1% 0.9 1.1 <0.1% <0.1% 1.0 1.1 <0.1% <0.1% 1.1
D56 1.1 <0.1% <0.1% 0.9 1.2 <0.1% <0.1% 0.9 1.1 <0.1% <0.1% 1.0
12 No NR CD4 D0 <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% 1.0 0.9 <0.1% <0.1% 1.7 0.7
D56 <0.1% <0.1% <0.1% 1.2 <0.1% <0.1% 1.4 1.6 <0.1% <0.1% 1.0 1.3
CD8 D0 <0.1% <0.1% <0.1% 1.0 <0.1% <0.1% <0.1% 1.1 <0.1% <0.1% <0.1% <0.1%
D56 0.7 <0.1% <0.1% 0.9 0.7 <0.1% 1.8 0.9 0.5 <0.1% <0.1% 0.9
13 No PR CD4 D0 <0.1% <0.1% <0.1% 1.8 <0.1% <0.1% <0.1% 1.8 <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% 1.9 <0.1% <0.1% <0.1% 1.7 <0.1% <0.1% <0.1% <0.1%
CD8 D0 <0.1% <0.1% <0.1% 0.7 <0.1% 1.0 <0.1% 1.0 <0.1% <0.1% <0.1% <0.1%
D56 <0.1% 0.8 <0.1% 0.7 <0.1% 0.6 <0.1% 0.9 <0.1% <0.1% <0.1% 1.2
14 No NR CD4 D0 <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% 1.9 <0.1% <0.1% <0.1% 1.2 <0.1% <0.1% <0.1% <0.1%
CD8 D0 <0.1% <0.1% 0.6 0.8 <0.1% <0.1% 1.0 0.7 <0.1% <0.1% <0.1% <0.1%
D56 <0.1% <0.1% <0.1% 0.8 <0.1% <0.1% <0.1% 0.9 <0.1% <0.1% 1.1 0.6

Numbers represent the fold change over background (unloaded APCs). n.d.: no positive cells detected. Fold changes greater than two are highlighted in green. <0.1% indicates that the fraction of positive cells was less than 0.1% from its parent (CD4+ or CD8+ T cells).

CR, complete response; IFNγ, interferon gamma; IL2, interleukin 2; NR, no response; PR, partial response; TNFa, tumor necrosis factor alpha.